SEBI relaxes compliance related to Credit Rating Agencies

The Securities and Exchange Board of India in its notification dated 30th March 2020, has decided to grant relaxations from compliance with certain provisions under the SEBI (Credit Rating Agencies) Regulations, 1999, due to the COVID-19 pandemic and moratorium permitted by RBI.

SEBI extends second phase of UPI implementation for retail investors

The Securities and Exchange Board of India vide its notification dated 30th March 2020 has decided to continue with the current phase II of Unified Payments Interface (UPI) with Application Supported by Blocked Amount due to Covid-19 virus pandemic. The modalities for the implementation of Phase III of the UPI ASBA shall be notified later after deliberations with stakeholders.

Government introduces price control on medical device

The Ministry of Chemicals and Fertilizers vide its notification dated 31st March 2020 has stated that the medical devices intended for use in human beings or animals shall be regulated by the government as drugs for quality control and price monitoring.